Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Stomach Neoplasms 4Neoplasm Metastasis 4Colorectal Neoplasms 4Immunotherapy Gastrict Cancer 1HER-2 Negatived Gastric Cancer 1Gastrointestinal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Advanced NSCLC With EGFR Mutation 1Advanced Gastric Cancer 1Advanced Gastric Adenocarcinoma 1

Interventions

S 1 (combination) 1Gefitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Advanced NSCLC With EGFR Mutation × S 1 (combination) × Clear all
NCT03457337 2020-07-10

S-1 Plus Gefitinib Versus Gefitinib Monotherapy in Patients With EGFR-sensitive Mutation Advanced Non-squamous NSCLC

Henan Cancer Hospital

Phase 2 Unknown
200 enrolled
Thoracic

Advanced NSCLC With EGFR Mutation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡